Our results concur with the largest published study for IgG aDI in 442 aβ2GPI-positive subjects (of which 82% had APS), underlining the added value of measuring IgG aDI as well as aCL/aβ2GPI in relation to increased risk of VT [21]. Here, ACLY is linked to autoimmune polyendocrinopathy.